JAZZ logo

Jazz Pharmaceuticals, Inc.

JAZZ

JAZZ: Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

more

Show JAZZ Financials

Chart and Financial Data provided by TradingView

All
Government
Consumer Interest
SEC Filings
ESG/Other
Congress Trading

Recent trades of JAZZ by members of U.S. Congress

Politician Type Traded
Daniel Goldman House / D Sale $15,001 - $50,000 Jul. 12, 2023
Daniel Goldman House / D Purchase $15,001 - $50,000 Mar. 06, 2023
Daniel Goldman House / D Sale $1,001 - $15,000 Jan. 31, 2023
Thomas Suozzi House / D Purchase $1,001 - $15,000 Oct. 19, 2021
Bill Flores House / R Purchase $15,001 - $50,000 Jul. 15, 2019
Carlos Curbelo House / R Purchase $1,001 - $15,000 Aug. 28, 2018
Thomas Macarthur House / R Sale $1,001 - $15,000 May. 27, 2015
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by JAZZ's directors and management

Corporate Lobbying

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Sensitive drug distribution systems and methods Sep. 27, 2022
  • Patent Title: Sensitive drug distribution systems and methods Aug. 09, 2022
  • Patent Title: Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances Dec. 28, 2021
  • Patent Title: Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances Aug. 17, 2021
  • Patent Title: Devices and methods for facilitating and controlling use of a medication Jun. 15, 2021
  • Patent Title: Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances Apr. 27, 2021
  • Patent Title: Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances Apr. 06, 2021
  • Patent Title: Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances Mar. 30, 2021
  • Patent Title: Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances Oct. 27, 2020
  • Patent Title: Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances Sep. 01, 2020
  • Patent Title: Devices and methods for facilitating and controlling use of a medication Oct. 31, 2017
  • Patent Title: Immediate release formulations and dosage forms of gamma-hydroxybutyrate Oct. 24, 2017
  • Patent Title: Method for administering ω-conopeptide Jul. 18, 2017
  • Patent Title: Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy Jan. 10, 2017
  • Patent Title: Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy Feb. 10, 2015
  • Patent Title: Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy Oct. 14, 2014
  • Patent Title: Immediate release formulations and dosage forms of gamma-hydroxybutyrate Jul. 15, 2014
  • Patent Title: Method of administration of gamma hydroxybutyrate with monocarboxylate transporters Jul. 08, 2014
  • Patent Title: Immediate release dosage forms of sodium oxybate Jul. 08, 2014
  • Patent Title: Method for administering omega-conopeptide Jul. 01, 2014
  • Patent Title: Sensitive drug distribution system and method May. 20, 2014
  • Patent Title: Pharmaceutical compositions of clonazepam and method of use thereof May. 06, 2014
  • Patent Title: Method for administering omega-conopeptide Feb. 18, 2014
  • Patent Title: Pharmaceutical compositions of benzodiazepines and method of use thereof Dec. 17, 2013
  • Patent Title: Sensitive drug distribution system and method Nov. 19, 2013
  • Patent Title: Pharmaceutical formulation for reducing pain Aug. 20, 2013
  • Patent Title: Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy Jun. 11, 2013
  • Patent Title: Sensitive drug distribution system and method Jun. 04, 2013
  • Patent Title: Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy Dec. 04, 2012
  • Patent Title: Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy Sep. 11, 2012
  • Patent Title: Sensitive drug distribution system and method Feb. 22, 2011
  • Patent Title: Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy Dec. 14, 2010
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of JAZZ in WallStreetBets Daily Discussion

JAZZ News

Recent insights relating to JAZZ

CNBC Recommendations

Recent picks made for JAZZ stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in JAZZ

Corporate Flights

Flights by private jets registered to JAZZ